• 1
    Coleman M, Esteve J, Damiecki P, Arslan A, Renard H. Trends in cancer incidence and mortality. Lyon: IARC, 1993.
  • 2
    BerrinoF, CapocacciaR, EstèveJ, GattaG, HakulinenT, MicheliA, SantM, VerdecchiaA, editors. Survival of cancer patients in Europe: the EUROCARE-2 study. Lyon: IARC, 1999.
  • 3
    Verdecchia A, Mariotto A, Gatta G, Texeira MTB, Ajiki W. Comparison of stomach cancer incidence and survival in four continents. Eur J Cancer 2003; 39: 16039.
  • 4
    ParkinDM, WhelanSL, FerlayJ, RaymondL, YoungJ, editors. Cancer incidence in five continents. vol. 7. Lyon: IARC, 1997.
  • 5
    Sant M, EUROCARE Working Group. Differences in stage and therapy for breast cancer across Europe. Int J Cancer 2001; 93: 894901.
  • 6
    Gatta G, Capocaccia R, Sant M, Bell CMJ, Coebergh JWW, Damhuis RAM, Faivre J, Martinez-Garcia C, Pawlega J, Ponz de Leon M, Pottier D, Raverdy N, Williams EMI, Berrino F. Understanding variations in colorectal cancer survival in Europe: a EUROCARE high-resolution study. Gut 2000; 47: 5338.
  • 7
    Hakulinen T, Tenkanen L. A regression analysis of relative survival rates. Appl Stat 1987; 36: 30917.
  • 8
    SAS/STAT. Changes and enhancements through release 6.11. Cary, NC: SAS Institute, 1996.
  • 9
    Msika S, Benhamiche AM, Rat P, Faivre J. Pronostic à long terme du cancer gastrique dans la population de Côte d'Or. Gastroenterol Clin Biol 2000; 24: 64955.
  • 10
    Forman D. Counting cancers at the junction: a problem of routine statistics. Eur J Gastroenterol Hepatol 2002; 14: 99101.
  • 11
    Nakajima T. Gastric cancer treatment guidelines in Japan. Gastr Cancer 2002; 5: 15.